FDA Recall Terminated

Randox Liquid Cardiac Controls Catalogue Number CQ5052.

Recall: Z-0413-2020 · Initiated October 4, 2019

Recall

Recall Number
Z-0413-2020
Event Number
84044
Firm
Randox Laboratories, Limited Ardmore; 55 The Diamond Road Crumlin United Kingdom
FEI Number
1000361607
Product Code
JJY
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
October 4, 2019
Terminated
July 6, 2020

Description

Randox Liquid Cardiac Controls Catalogue Number CQ5052.

Reason

Removal of claims for N-proBNP in the Liquid Cardiac Control catalogue number CQ5052 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Action

On October 1, 2019 the firm distributed Urgent Medical Device Recall letters by e-mail instructing them to: - Inspect your stock and quarantine affected stock. - Replace the value sheet in the kit with the revised value sheet provided. - Randox is not recommending a review of previous results as changes in quality control recovery would be reviewed at the time of occurrence. - Discuss the contents of this notice with your Medical Director. - Complete and return the response form 12187-QA to [email protected] within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organization.

Distribution

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

Quantity

7,505